Abstract
Infants and young children who have brain tumors have a poor rateof survival and high treatment associated morbidity. A trial of mechlorethamine, vincristine (oncovin), procarbazine, and prednisone(MOPP) was performed to test the hypothesis that replacingradiotherapy with chemotherapy would improve survival and decreaselong term morbidity of infants who have brain tumors. Between 1976 and1988, 17 consecutive children less than 36 months old when diagnosed with medulloblastoma or ependymoma were treatedwith MOPP chemotherapy as primary therapy following surgical excision or biopsy of the tumor. Radiotherapy was reserved for recurrent disease. Ten of 17 children have survived without evidence of disease: medulloblastoma, eight of 12 with median survivaltime of 10.6 years (range, 6.2 to 15.2 yrs); and ependymoma, 2of 5 (at 13.0 and 16.0 yrs). Four of the 10 children with medulloblastomaand ependymoma who relapsed are now disease free at 7.5, 11.7, 12.2 and 13.5 yrs post relapse after receiving salvagetherapy with cisplatin (n = 1) or irradiation (n = 3). All relapsesoccurred within 26 months of diagnosis. Data on growth demonstrated heightless than the 5th percentile in all children who received cranial irradiation compared to 25 to 95th percentile for nonirradiated children. Intellectual ability for the groupwho did not require radiation was within normal range (mean IQ 100.1) and stable across annual assessments. Those who required radiation hadlower IQs which continued to decline over time (mean IQ 85 at mean age of 5.8 years, declining to 63 at 10 years).In young children with brain tumors, primary chemotherapy with MOPP, omitting radiotherapy, provides improved neurodevelopmental outcome and survival.
Similar content being viewed by others
References
Tomita R, McLone DG: Brain tumors during the first twenty-four months of life. Neurosurgery 17: 913–920, 1985
Moore BD III, Ater JL, Copeland D: Improved neuropsychological outcome in young children with brain tumors treated without irradiation. J Child Neurol 7: 281–290, 1992
Ellenberg L, McComb JG, Siegel SE, Stowe S: Factors affecting intellectual outcome in pediatric brain tumor patients. Neurosurgery 21: 638–644, 1987
Mulhern RK, Horowitz ME, Kovnar EH, Langston J, Sanford RA, Kun LE: Neurodevelopment status of infants and young children treated for brain tumors with pre-irradiation chemotherapy. J Clin Oncol 7: 1660–1666, 1989
Chin HW, Maroyama Y: Age at treatment and long term performance results in medulloblastoma. Cancer 53: 1952–1958, 1984
Cangir A, van Eys J, Hvizdala E, Morgan SK: Combination chemotherapy with MOPP in children with recurrent brain tumors. Med Pediatr Oncol 41: 253–261, 1978
van Eys J, Baram TZ, Cangir A, Bruner JM, Martinez-Prieto J: Salvage chemotherapy for recurrent primary brain tumors in children. J Pediatr 113: 601–606, 1988
Krischer JP, Ragab AH, Kun L, Kim TH, Laurent JP, Boyett JM, Cornell CJ, Link M, Luthy AR, Camitta B: Nitrogen mustard, vincristine, procarbazine and prednisone as adjuvant chemotherapy in medulloblastoma: A pediatric oncology group study. J Neurosurg 74: 904–909, 1991
van Eys J, Cangir A, Coody D, Smith B: MOPP regimen as primary chemotherapy for brain tumors in infants. J Neurooncol 3: 237–243, 1985
Baram TZ, van Eys J, Dowell RE, Cangir A, Pack B, Bruner JM: Survival and neurologic outcome of infants with medulloblastoma treated with surgery and MOPP chemotherapy. Cancer 60: 173–177, 1987
Duffner PK, Horowitz ME, Krischer JP, Friedman HS, Burger PC, Cohen ME, Sanford RA, Mulhern RK, James HE, Freeman CR, Seidel FG, Kun LE: Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med 328: 1725–1731, 1993
Harisiadis L, Chang CH: Medulloblastoma in children: A correlation of staging with results of treatment. Int J Radiat Oncol Biol Phys 9: 833–842, 1977
McCarthy D: McCarthy scales of children’s abilities. New York, The Psychological Corp, 1972
Wechsler D: Wechsler intelligence scale for children–revised. New York, The Psychological Corp, 1974
Thorndike RL, Hagen EP, Sattler JM: Stanford-Binet intelligence scale (ed 4). Chicago, The Riverside Publishing Co, 1986
Fleiss JL: Statistical methods for rates and proportions (ed 2). New York, John Wiley & Sons, 1981
Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. Journal of the American Statistical Association 53: 457–481, 1958
Peto R, Peto J: Asymptotically efficient rank in variant test procedures. Journal of the Royal Statistical Society 135: 185–206, 1972
Zeltzer PM, Friedman HS, Norris DG, Ragab AH: Criteria and definitions for response and relapse in children with brain tumors. Cancer 56: 1824–1826, 1985
Horowitz ME, Mulhern RK, Kun LE, Kovnar E, Sanford RA, Simmons J, Hayes IA, Jenkins JJ: Brain tumors in the very young child–postoperative chemotherapy in combined-modality treatment. Cancer 61: 428–434, 1988
Geyer JR, Zeltzer PM, Boyett JM, Rorke LB, Stanley P, Albright AL, Wisoff JH, Milstein JM, Allen JC, Finlay JL, Ayers GD, Shurin SB, Stevens KR, Bleyer WA: Survival of infants with primative neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: a report from the Childrens Cancer Group.J Clin Oncol 12: 1607–1615, 1994
Goldwein JW, Radcliffe J, Packer RJ, Sutton LN, Lange B, Rorke LB, D’Angio GJ: Results of a pilot study of low-dose craniospinal radiation therapy plus chemotherapy for children younger than 5 years with primative neuroectodermal tumors. Cancer 71: 2647–2652, 1993
Torres CF, Rebsamen S, Silber JH, Sutton LN, Bilaniuk LT, Zimmerman RA, Goldwein JW, Phillips PC, Lange BJ: Surveillance scanning of children with medulloblastoma. N Engl J Med 330: 892–895, 1994
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ater, J.L., Eys, J.v., Woo, S.Y. et al. MOPP chemotherapy without irradiation as primary postsurgical therapy for brain tumors in infants and young children. J Neurooncol 32, 243–252 (1997). https://doi.org/10.1023/A:1005744527443
Issue Date:
DOI: https://doi.org/10.1023/A:1005744527443